211915-06-9: Dabigatran Etexilate
Dabigatran Etexilate(CAS No: 211915-06-9) or :3-{[(2-{[(4-{N’-hexyloxycarbonyl carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-pyridin-2-yl-amino)propanoic acid ethyl ester, is a potent, concentration-dependent inhibitor of thrombus formation and prevention of venous thromboembolism
Additional information on CAS 211915-06-9
Catalogue No.
VE008337
CAS No.
211915-06-9
Molecular Formula
C34H41N7O5
Molecular Weight
627.73 g/mol
Parent drug
Dabigatran
IUPAC Name
3-{[(2-{[(4-{N'-hexyloxycarbonyl carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-pyridin-2-yl-amino)propanoic acid ethyl ester
Synonyms
N/A
References
Dabigatran Etexilate By Mark Sanford, Greg L Plosker Container: Drugs Year: 2008 Volume: 68 Issue: 12 DOI: 10.2165/00003495-200868120-00007 URL: https://link.springer.com/article/10.2165/00003495-200868120-00007
Status
In-stock
